Last €76.52 EUR
Change Today +0.71 / 0.94%
Volume 266.3K
SAN On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 5:25 AM 07/14/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Olivier Jacquesson

Former Senior Vice President of Business Development and Member of Management Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 10 board members in 2 different organizations across 3 different industries.

See Board Relationships
64--

Background*

Mr. Olivier Jacquesson served as Senior Vice President, Business Development of Sanofi-Aventis from August 30, 2004 to December 31, 2006. Mr. Jacquesson has had a long career within Sanofi-Aventis since joined in 1976. He served as head of the Roussel-Uclaf subsidiaries in Belgium and Mexico. After having managed several divisions, he served as the head of Roussel-Uclaf worldwide since 1994. Since 1997, he has managed the France-based businesses of Hoechst Marion Roussel ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

Co-Chairman

Education*

Bachelor's Degree
Institut Administration Des Entreprises

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €76.50 EUR +0.69

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.